# LENZ Therapeutics, Inc.: Form 8-K, filed Apr 4, 2025

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: 8-K
- Filed: 2025-04-04
- Accepted by EDGAR: Apr 4, 2025, 20:54 ET
- Period: 2025-04-04
- Accession: 0001628280-25-016824
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/lenz-20250404.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000162828025016824/lenz-20250404.htm

Filed Apr 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-016824. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.